Connect with us

Media OutReach

Beijing Tong Ren Tang Joins Hands with CMHK Education Platform – Edubile to Launch Inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care

Published

on

“Inheriting Traditional Chinese Medicine, Inspiring a Smarter Future”

HONG KONG SAR – Media OutReach Newswire – 25 March 2025 – Beijing Tong Ren Tang has a brand history spanning over 350 years. Beijing Tong Ren Tang Chinese Medicine Company Limited (“Beijing Tong Ren Tang”) (3613.HK) in Hong Kong is committed to promoting the legacy of traditional Chinese medicine culture and supporting the industry’s long-term development. Recently, the company held a Plaque Cleansing (Complimenting) Ceremony at its Research and Development Production Plant at Tai Po Industrial Estate to celebrate the annual global “Tong Ren Tang Day,” reaffirming its commitment to uphold virtues, nurture culture, and sustain traditional craftsmanship. Today, Beijing Tong Ren Tang officially announced its series of activities for 2025, highlighting the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care.”

(Photo 1) With a prestigious royal medicine brand history of over 300 years, Beijing Tong Ren Tang Chinese Medicine Company Limited recently held a Plaque Cleansing (Complimenting) Ceremony at its Research and Development Production Plant and Cultural Museum at Tai Po Industrial Estate to celebrate the annual global “Tong Ren Tang Day.”

The “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” is organized by Beijing Tong Ren Tang and supported by China Mobile Hong Kong Company Limited (“CMHK”) through its education platform “Edubile”. The programme combines Tong Ren Tang’s over 350 years of traditional Chinese medicine wisdom with Edubile’s 5G+AIoT technologies, providing participating schools with a specially designed course named “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” that integrates STEAM education elements. The course aims to fuel Hong Kong students’ interest in traditional Chinese medicine culture and modern technology. It also seeks to enhance their awareness of career planning, nurture a new generation of student ambassadors promoting traditional Chinese medicine culture, and actively contribute to the development of community health.

Today, Beijing Tong Ren Tang held a launch ceremony for the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” at its Research and Development Production Plant at Tai Po Industrial Estate. Distinguished officiating guests included Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Liu Gang, Factory Manager of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited, and Mr. Wong Wai Lung, Senior Product Manager (Education Product), China Mobile Hong Kong Company Limited.

(Photo 2) Beijing Tong Ren Tang collaborates with China Mobile Hong Kong’s Education Platform “Edubile” to launch the inaugural "Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care" and activate the "Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course." Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited (Left) and Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited (Right) hosted the launching ceremony that marks the integration of traditional Chinese medicine wisdom with innovative technologies. Inheriting Traditional Chinese Medicine, Inspiring a Smarter Future.
(Photo 2) Beijing Tong Ren Tang collaborates with China Mobile Hong Kong’s Education Platform “Edubile” to launch the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” and activate the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course.” Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited (Left) and Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited (Right) hosted the launching ceremony that marks the integration of traditional Chinese medicine wisdom with innovative technologies. Inheriting Traditional Chinese Medicine, Inspiring a Smarter Future.

Speaking at the ceremony, Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited, said, “With a brand history of over 350 years, Beijing Tong Ren Tang is dedicated to passing on the essence and wisdom of traditional Chinese medicine to benefit society and the world. We are thrilled to be supported by China Mobile Hong Kong’s education platform Edubile. By integrating the knowledge of traditional Chinese medicine with smart and innovative technologies, we bring a wealth of diverse experiences to campus for teachers and students. Our goal is to deepen public understanding, preserve this rich cultural heritage, and promote healthier lifestyles.”

Mr. Chen Ning Jie, Assistant General Manager, Product Centre at China Mobile Hong Kong Company Limited, stated that CMHK was honored to collaborate with Beijing Tong Ren Tang through Edubile, jointly promoting the convergence of culture, education, and technology while proactively nurturing the next generation of talent. He mentioned that by leveraging CMHK Edubile’s proprietary 5G+AIoT technologies, they provided students with immersive and interactive learning experiences, which included cultivating and observing the growth cycles of Chinese medical herbs. Such an approach would inspire students’ research spirit and creative thinking. Mr. Chen expressed that China Mobile Hong Kong looked forward to working closely with Beijing Tong Ren Tang to create a new landscape in education.

(Photo 3) Guests attending the launch ceremony of the inaugural "Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” (from Left to Right) : Mr. Liu Gang, Factory Manager of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited and Mr. Wong Wai Lung, Senior Product Manager (Education Product), China Mobile Hong Kong Company Limited.
(Photo 3) Guests attending the launch ceremony of the inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” (from Left to Right) : Mr. Liu Gang, Factory Manager of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Fei, Executive Director of Beijing Tong Ren Tang Chinese Medicine Company Limited; Mr. Chen Ning Jie, Assistant General Manager, Product Centre, China Mobile Hong Kong Company Limited and Mr. Wong Wai Lung, Senior Product Manager (Education Product), China Mobile Hong Kong Company Limited.

The inaugural “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” offers the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course,” covering four major areas: theoretical knowledge, practical experiments, expert interactive learning, and community engagement. The course provides in-depth knowledge of Chinese medical herb cultivation techniques, medicinal herb knowledge, and modern developments in Chinese medicine. It also includes practical components, such as making Chinese medicine herbal sachets, to enhance enjoyment and stimulate student participation.

Through the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” students will learn to cultivate various types of Chinese medicinal herbs, utilizing CMHK Edubile’s 5G+AIoT technologies to observe, record, and analyze plant growth data. Participants will also have the unique opportunity to visit Beijing Tong Ren Tang’s Research and Development Production Plant and Cultural Museum at Tai Po Industrial Estate, as well as CMHK 5G Lab, interacting and exchanging insights with traditional Chinese medicine experts and technology specialists. This experience enhances students’ understanding of the Chinese medicine industry and its technological applications. The comprehensive program fosters awareness of traditional Chinese medicine culture, inspires interest in its practices, and encourages creative thinking through practical experiences, achieving interdisciplinary educational innovation.

The “Hong Kong Student Ambassador Programme for Chinese Medicine and Health Care” is now open for enrolment for local primary and secondary school students. Upon completion of the course and community activities, participants will be awarded the “Tong Ren Smart Green Chinese Herbal Medicine Cultivation Course” Certificate and become “Hong Kong Student Ambassador for Chinese Medicine and Health Care”. For more details and enrolment information, please contact the programme coordinator via email at btrtapplication@gmail.com on or before 30 March 2025.Hashtag: #BeijingTongRenTang #Edubile #ChineseMedicine #StudentAmbassador #Education #SmartGreen


The issuer is solely responsible for the content of this announcement.

About Tong Ren Tang Day

On the 18th day of the second lunar month in the year 1723 (during the reign of Emperor Yongzheng), the Imperial Medical Bureau official, Liu Shengfang, submitted the memorial to the throne. Emperor Yongzheng approved the supply of medicinal materials from the Tong Ren Tang pharmacy for use in the Imperial Palace. This marked the beginning of a unique 188-year tradition of providing medicinal supplies to the Qing dynasty palace. As a result, the 18th day of the second lunar month was designated as ‘Tong Ren Tang Day’.

About Beijing Tong Ren Tang

Tong Ren Tang was founded in 1669, and has a history of 356 years. The company has always adhered to its corporate motto of “No compromise on cost and labour despite the complexity of processing herbal medicine. No compromise on quality and standard despite the scarcity of medicine ingredients.” This commitment has led Beijing Tong Ren Tang to steady development, lasting through every generation, achieving excellence, and becoming a national treasure while expanding globally.

At the same time, Beijing Tong Ren Tang has taken on the mission of promoting traditional Chinese medicine culture, actively participating in domestic and international traditional Chinese medicine promotion activities, facilitating cultural exchanges around the world, and striving to expand the international influence of traditional Chinese medicine. To date, it has been operating over 160 retail branches in 26 countries and regions overseas, making it one of the most recognized traditional Chinese medicine brands internationally.

About Beijing Tong Ren Tang Chinese Medicine Company Limited

In 2004, Tong Ren Tang expanded its operations overseas by establishing Beijing Tong Ren Tong Chinese Medicine Company Limited in Hong Kong. Ahering to the corporate belief of “Nurturing kindness and virture, Preserving tranquility and wellness”, and with the mission of “Healthy Life, Globally Choice”, the company is based in Hong Kong while strategically positioning itself worldwide. It carries the mission of promoting traditional Chinese medicine culture outside mainland China. By employing a model that integrates medical services with medicine and emphasizes cultural outreach, the company is driving forward the internationalization of traditional Chinese medicine. (Beijing Tong Ren Tong Chinese Medicine Company Limited website: )

About New Product Research and Development

Beijing Tong Ren Tang Chinese Medicine Company Limited actively develops a variety of registered Traditional Chinese patent medicines and health products, embodying the philosophy of “Health Life, Globally Choice.” This year, the company has introduced a registered Chinese medicine specifically designed for the prevention and treatment of non-alcoholic fatty liver disease (NAFLD) – Lingzhi Jianghuang Fufang Huoxue Anshen Capsules, which includes Ganoderma and turmeric compound for invigorating qi and tranquilizing the mind.. This product features a unique formula containing ingredients such as Ganoderma, turmeric, magnolia berry, and , and kudzu root. It offers a range of benefits, including promoting blood circulation and energy flow, quenching thirst, replenishing energy, and calming the mind. With its “cleanse, regulate, and nourish” three-in-one functionality, the product can reduce visceral fat, harmonize the body, and ultimately repair and protect the liver. Last year, the company’s research and development team collaborated with one of the local well-known universities on the “Pharmacodynamic and mechanism study of Lingzhi-Jianghuang Formula (LJF) extract on NAFLD in mice” was funded by Hong Kong Research Grants Council under Research Matching Grant Scheme. It is a strongly supportive study for the product’s efficacy. Furthermore, the company has created awide range of high-quality health products to comprehensively care for public health.

About Edubile

In support of the Hong Kong SAR Government’s strategic direction in nurturing technological talent, China Mobile Hong Kong (CMHK) has launched its education platflorm “Edubile”. Drawing on its strengths in 5G and AI technologies, Edubile aims to drive digital transformation across campuses, fostering a new generation of innovation and technology leaders. Guided by its vision of “Bringing 5G+AI Technology into Campuses”, Edubile has developed speciialised educational content and e-learning platforms for educational purposes. By integrating advanced 5G networks with smart campus applications, the initiative significantly enhances school management efficiency and teaching quality, facilitating comprehensive improvements in both teaching methodologies and administrative processes.

Additionally, Edubile has introduced Hong Kong’s first-ever “5G+Green Technology” course, entitled “Smart Green Campus”. This pioneering programme combines 5G technology, the Internet of Things (IoT), and artificial intelligence to assist teachers and students in collaboratively designing campus-based Chinese medicinal gardens and environmentally friendly gardens. The curriculum not only deepens students’ appreciation of traditional Chinese medicine culture but also cultivates their environmental awareness and innovative thinking through practical technological applications, achieving interdisciplinary educational innovation.

Looking forward, China Mobile Hong Kong will continue to deepen the integration of 5G+AI technologies with innovation and technology education. Through organising diverse educational activities and developing advanced smart educational solutions, CMHK is committed to supporting the creation of a sustainable technology education ecosystem in Hong Kong, nurturing digitally competitive talent for the society of tomorrow.

About China Mobile Hong Kong Limited

China Mobile Hong Kong Company Limited (“CMHK”) is the wholly-owned subsidiary of China Mobile Limited (HKEx: 941), which is listed on the Fortune Global 500. CMHK was incepted in January 1997 and was the first mobile network operator to launch PCS services in Hong Kong.

As the world’s leading mobile network brand with the largest customer base*, The Company offers innovative and comprehensive communications services, including voice, data, IDD and international roaming through 5G, 4G LTE and 3GHSPA and other technologies. The Company is committed to the development of 5G with new technologies such as artificial intelligence, internet of things, cloud computing and big data, integrating 5G applications in different industries, promoting the construction and development of smart city groups in Greater Bay Area.

*China Mobile (Hong Kong) Limited is a wholly-owned subsidiary of China Mobile Limited. As of 31 December 2023, China Mobile Limited had the largest number of mobile network subscribers in the world.

Media OutReach

“One Earth Summit” 2025 Held Successfully Hong Kong Fully Leverages Its Role as an International Financial Center and Leader in Green Finance

Published

on

Laying a Solid Foundation for the Development of ESG Investment and Green Innovation

  • Calling for Global Collaboration Among Governments, Businesses, and Philanthropic Organizations to Effectively Address Climate Change
  • Over 300 Influential Leaders and Change-makers Gather in Hong Kong to Plan the Path Forward for a Sustainable Future

HONG KONG SAR – Media OutReach Newswire – 28 March 2025 – The “One Earth Summit,” hosted by the Institute of Sustainability and Technology and co-organized with the One Earth Alliance and the Giving to Amplify Earth Action (GAEA) initiative launched by the World Economic Forum, was held today at the Regala Skycity Hotel.

The theme of the forum was “Driving Systemic Change Towards a Sustainable Future through Impact Investment and Technological Innovation.” The event attracted over 300 influential leaders and change-makers from various sectors including finance, startups, foundations, media, civil society organizations, and academia from around the world, focusing on dialogue aimed at actionable solutions to respond to global population growth.

In his speech, Mr Paul Chan Mo-po, Financial Secretary, The Government of the Hong Kong Special Administrative Region stated, “As an international financial center and a leader in green finance, Hong Kong can help bridge the funding gap for green projects. Hong Kong’s issuance of green bonds has ranked first in the Asian market for seven consecutive years, with a market share reaching approximately 45% last year. At the same time, Hong Kong is seeking innovative financing solutions, such as tokenized green bonds and infrastructure financing securitization, to attract new investors. Hong Kong is committed to achieving carbon neutrality before 2050, focusing on three major strategies: zero-carbon power generation, green buildings, and sustainable transportation, as well as waste reduction. Global measures to tackle climate change create new business opportunities in burgeoning markets for green products and services. The budget announced earlier this month includes the establishment of a GreenTech Hub, which will accommodate 200 technology firms and serve as a nexus for public-private partnerships and international collaboration, with hopes that more private capital will drive green technology development and build a prosperous ecosystem. Additionally, artificial intelligence has widespread applications in sustainable development, emphasizing the government’s recognition of the significant potential of incorporating AI into the green ecosystem, designating it as a core industry.”

Professor Poman Lo, Chair of One Earth Summit Board of Advisory, Founder of Institute of Sustainability and Technology; Vice Chairman of Regal Hotels Group, remarked in her welcoming speech, “, We are a massive hub of human capital, talent, and innovation. Asia can surely play a pivotal role in leading the global net zero transition. One Earth Summit is part of the major transformation underway to bring Hong Kong closer to our ambition of being an international hub for sustainable finance and green innovation.”

Additionally, Mr Rob Van Riet, Senior Special Adviser to Managing Board, World Economic Forum, and Mrs Amy Lo, Chairman of UBS Global Wealth Management Asia, Head and Chief Executive, UBS Hong Kong, also delivered speeches on the future of sustainable technology and finance before the official start of the forum.

During the forum, speakers focused on three major topics, including:

  • Buildings and Transportation: Exploring the future development of green buildings and smart transportation;
  • Energy Transition: Sharing the latest technologies and investment opportunities in renewable energy and energy IoT;
  • Food and Water Resources: Analyzing global strategies for sustainable management of food and water resources.

For more event information, please visit the forum’s website: www.oneearthsummit.org/
Hashtag: #InstituteofSustainabilityandTechnology #OneEarthSummit

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Diabetes Association Unveils T-CaReMe Taipei Declaration at the Asia Diabetes International Conference

Published

on

In an effort to achieve a target of 80% of patients controlling the three highs and protecting kidney health within eight years, Taiwan leads the international trend of precise prevention with public-private collaboration in response to the new health goals of Healthy Taiwan.

TAIPEI, TAIWAN – Media OutReach Newswire – 28 March 2025 – As the global aging process accelerates, the prevention and care of chronic diseases have become a top priority for countries worldwide. The Taiwanese government has actively responded to international trends by promoting the “Healthy Taiwan” policy and launching the “Three Highs Prevention 888 Plan.” At the third “Healthy Taiwan Promotion Committee” meeting held last month, new goals were announced to reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030, aiming to strengthen chronic disease prevention and control measures through public-private collaboration. In alignment with the vision of “Healthy Taiwan” and the 888 Plan, and connecting with the international trend of “precision prevention” of chronic disease management, the Taiwan Diabetes Association formally presented the “T-CaReMe Precision Care Taipei Declaration” at the Asia Diabetes International Conference.

Figure 1: Group photo of the T-CaReME Taipei Declaration, from left to right are: Vice Chairman Li Wen-Ling, Secretary-General Hsu Yong-He, Supervisor Chuang Li-Min, Director Wu Chao-Jun, Director Shih Chong-Liang, Professor Yutaka Seino, Chairman Huang Chien-Ning, Academician Chen Chien-Jen, Professor Moon-Kyu Lee, Professor Daisuke Yabe, Vice President Hsu Hui-Heng, and Chairman Ouh Hong-Yi.

With a comprehensive national health insurance system in place, Taiwan ensures that every high-risk group can receive proactive prevention and personalized management early on, demonstrating international competitiveness in the accessibility and completeness of chronic disease care. To address the increasingly severe challenge of chronic diseases—particularly hypertension, hyperlipidemia, diabetes (the three highs), and chronic kidney disease—the Taiwan Diabetes Association unveiled the “T-CaReMe Precision Care Taipei Declaration” at the 17th Scientific Meeting of the Asian Association for the Study of Diabetes (AASD). This declaration was made in witness of various governmental agencies, academic institutions, and medical associations, including the Asian Association for the Study of Diabetes, the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, the National Health Research Institutes, the Taiwan Society of Nephrology, and the Taiwan Society of Cardiology. The declaration responds to the government’s vision of “Healthy Taiwan” and the goals of the 888 Plan, which focus on delaying disability and increasing life expectancy. It proposes a comprehensive health care model for chronic diseases centered around risk stratification, precision medicine, and digital management, further promoting the integration of holistic health care and medical services, while fostering interdisciplinary collaboration to drive a new paradigm of chronic disease prevention and treatment.

Figure 2: On the left is Academician Chen Chien-Jen from the Academia Sinica, and on the right is Chairman Huang Chien-Ning of the Chinese Society of Diabetes, together taking a commemorative photo for the announcement of the T-CaReMe Taipei Declaration.
Figure 2: On the left is Academician Chen Chien-Jen from the Academia Sinica, and on the right is Chairman Huang Chien-Ning of the Chinese Society of Diabetes, together taking a commemorative photo for the announcement of the T-CaReMe Taipei Declaration.

New Health Goals for Healthy Taiwan: Reduce Standardized Mortality Rate of Chronic Diseases Related to the Three Highs by One-Third

The Taiwan Diabetes Association Unveils T-CaReMe Declaration to Promote Precision Care Blueprint for Kidney Health in Relation to the Three Highs

With the trends of aging, prolonged illness, and the emergence of chronic diseases at younger ages, chronic disease prevention and management have become a global focus. Taiwan is following international trends by establishing the “Healthy Taiwan Promotion Committee,” which has set two major health goals for the next eight years: to increase the average life expectancy of the population from 79 to 82 years and to reduce the proportion of unhealthy life expectancy from 10% to 8%. To strengthen chronic disease management, the government recently announced a target at the Healthy Taiwan Promotion Committee meeting to “reduce the standardized mortality rate of chronic diseases related to the three highs by one-third by 2030,” along with comprehensive strategies promoting healthy lifestyles, obesity prevention, and holistic management of chronic diseases, through public-private collaboration to enhance health policies and reduce the risks of chronic diseases and disabilities.

The Taiwan Diabetes Association has released the “T-CaReMe Precision Care Taipei Declaration,” making “Kidney Protection in Relation to the Three Highs” a core focus. Through the T-CaReMe initiative, the vision of “risk stratification, precision medicine, digital management, and increased life expectancy” is implemented, along with five key action frameworks: promoting precise risk diagnostics, standardized clinical guidelines, personalized health management, data sharing, and interdisciplinary collaboration. The goal is to ensure that 80% of patients with the three highs and kidney disease achieve control of blood glucose, blood pressure, and blood lipids while ensuring that 80% of kidney disease patients receive care and medication guidance from care managers, thereby enhancing survival rates and improving health quality, creating a stronger defense for chronic disease care in the population.

Risk Stratification × Precision Medicine: T-CaReMe Initiative Launches a New Future for Chronic Disease Management

International Experts Gather to Establish Taiwan as a Demonstration Base for Chronic Disease Care

The T-CaReMe Taipei Declaration focuses on precise risk diagnostic classification and assessment, aiming to accurately identify high-risk populations and improve the effectiveness of chronic disease management. Through expert consensus and clinical risk stratification, as well as medical guidelines, the initiative integrates clinical data with international standards to ensure that patients receive personalized health management and appropriate treatment. Additionally, the declaration emphasizes collaboration across nations and disciplines, engaging in precision medicine and research achievements in the realm of chronic diseases in the Asia-Pacific region, influencing public health policies and improving chronic disease care outcomes, while developing a more precise and accessible holistic health care approach, solidifying Taiwan’s position as a regional demonstration base.

The meeting brought together experts and scholars from the National Health Insurance Administration, the Health Promotion Administration, Academia Sinica, and the National Health Research Institutes, along with representatives from the International Diabetes Federation (IDF-WPR) and the Asian Association for the Study of Diabetes (AASD), to witness the official launch of the “T-CaReMe Precision Care Taipei Declaration.” The Taiwan Diabetes Association stated that the declaration not only lays the groundwork for Taiwan’s development blueprint in precision chronic disease care and kidney health management related to the three highs but also aims to promote upgrades in chronic disease management models, enhance interdisciplinary collaboration, and build a more comprehensive health care system, driving improvements in global chronic disease care quality and prosperity starting from Taiwan.

Dr. Wu Mai-Su, President of the Taiwan Society of Nephrology, noted that although Taiwan has developed risk stratification and data-driven personalized treatment, standardized guidelines have yet to be incorporated, and clinical applications still have room for improvement, especially in the integrated management of kidney disease and diabetes. He expressed that through the T-CaReMe initiative, interdisciplinary collaboration can facilitate the integration of chronic kidney disease risk and comorbid management with diabetes and hypertension, contributing to higher patient survival rates and better kidney function maintenance. Dr. Li Yi-Heng, President of the Taiwan Society of Cardiology, emphasized that risk stratification and data-driven personalized management can effectively reduce the incidence of cardiovascular events, further strengthening the health defenses of the population. Dr. Hsu Hui-Heng, Deputy Director of the National Health Research Institutes, stated that the application of precision medicine will play a crucial role in future chronic disease management. The National Health Research Institutes is actively exploring several initiatives, such as using AI technology and big data to establish smart risk prediction systems, believing that under the visionary actions of the T-CaReMe initiative, there will be further optimization of precise predictions for cardiovascular, kidney, and metabolic disease risks, providing better scientific bases for the prevention of primary and secondary complications and organ damage associated with chronic diseases, thus realizing Taiwan’s health blueprint.

Aligning with International Standards! T-CaReMe Initiative Promotes a New Paradigm of Precision Chronic Disease Management

Taiwan will construct a comorbidity risk database within two years. The T-CaReMe initiative calls on all sectors to build a defense against chronic diseases.

In recent years, the Health Promotion Administration has actively promoted the “Scientific Disease Calculation Center” and risk prediction tools to enhance public health literacy and self-management awareness, delaying the onset of chronic diseases through proactive health education. Meanwhile, the National Health Insurance Administration has introduced AI risk stratification tools and a tiered care system, promoting the “Everyone’s Health Platform” and comprehensive, patient-centered care to improve care efficiency and resource utilization. Professor Chen Chih-Hong, Vice Convener of the Healthy Taiwan Promotion Committee, stated that the T-CaReMe initiative aligns closely with government policies integrating prevention and treatment, reflecting the core spirit advocated by the 888 Plan. In the future, it is hoped that all sectors will work together to deepen interdisciplinary collaboration and public-private integration, creating a sustainable and resilient model for chronic disease care.

The global healthcare community has identified precise risk assessment and personalized treatment as key trends in chronic disease management. The latest diabetes care guidelines particularly address the comorbidity risks associated with the three highs and kidney disease, suggesting earlier intervention in cardiovascular and kidney health management and enhancing data-driven diagnostic models. The importance of early screening and treatment is emphasized, and precise risk assessment and integration of patient data will be core development directions for future chronic disease management. These international trends indicate that global chronic disease management is moving towards precision medicine, digital monitoring, and interdisciplinary integration, which aligns closely with the goals of the T-CaReMe initiative.

The Taiwan Diabetes Association took action as early as 2023, collaborating with 12 medical institutions in Taiwan to join the iCaReMe global registry program. Through interdisciplinary integrated care, patient tracking, and the application of clinical data, it not only provides more precise risk assessments and patient profiles but also effectively monitors and optimizes treatment outcomes, which has been shown to improve patients’ health conditions. Chairman Huang Jian-Ning shared that the short-term goal of the T-CaReMe initiative is to construct a representative database within two years. By analyzing lifestyle factors, it aims to more accurately assess the comorbidity risks of different patients. Implementing a comprehensive model for precision chronic disease care requires not only efforts from the medical community but also active participation from government agencies, academic institutions, industry partners, and civic groups to jointly promote data integration and personalized health management, ensuring that risk stratification and standardized guidelines are continually refined, while enhancing chronic disease management effectiveness in Taiwan and the Asia-Pacific region.

Yutaka Seino, Chair of the Asian Association for the Study of Diabetes conference, stated that Taiwan has consistently been at the forefront of chronic disease prevention and treatment in Asia, and he hopes that through public-private collaboration and interdisciplinary cooperation, Taiwan can lead the global improvement of chronic disease care quality.
Hashtag: #DiabetesAssociation

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Li Ning Company Limited Announces 2024 Annual Results

Published

on

Strengthen the “Single Brand, Multi-Categories, Diversified Channels” Strategy | Solidify Brand and Product Competitiveness, Ensure Steady Operations, and Achieve Pragmatic Growth

HONG KONG SAR – Media OutReach Newswire – 28 March 2025 – Li Ning Company Limited (the “Company” or “Li Ning Company”; together with the subsidiaries, collectively, the “Group”; stock codes: 2331 (HKD counter) and 82331 (RMB counter)) announces today its 2024 annual results for the year ended 31 December 2024 (the “Year”).

Financial Results

In 2024, the Group’s annual performance was generally in line with expectations, a result of robust operational resilience and effective strategic execution. During the Year, the Group’s revenue amounted to RMB28,676 million, representing an increase of 3.9% as compared to that of 2023 (2023: RMB27,598 million). Gross profit amounted to RMB14,156 million, representing an increase of 6.0% compared to that of 2023(2023: RMB13,352 million). The overall gross profit margin increased by one percentage point to 49.4%(2023: 48.4%).

During the year, the net profit attributable to equity holders was RMB3,013 million (2023: RMB3,187 million). The margin of net profit attributable to equity holders was 10.5% (2023: 11.5%). Return on equity attributable to equity holders was 11.9% (2023: 13.1%). Basic earnings per share was RMB116.98 cents (2023: RMB123.21 cents). The Board has recommended the payment of final dividend of RMB20.73 cents per ordinary share for the year ended 31 December 2024, together with the interim dividend of RMB37.75 cents per ordinary share paid in September 2024, the total dividend for the year ended 31 December 2024 will amount to RMB58.48 cents per ordinary share or a total dividend payout ratio of 50%(2023: 45%).

In terms of cash flow management, the Group’s net cash generated from operating activities during the year amounted to RMB5,268 million (2023: RMB4,688 million). As at 31 December 2024, cash and cash equivalents (including cash at banks and in hand, and fixed term deposits with original maturity of no more than three months) amounted to RMB7,499 million, representing an increase of RMB2,055 million, as compared with the position as at 31 December 2023. Adding back the amount recorded as fixed-term deposits held at banks, cash balance amounted to RMB18,141 million, which represented a net increase of RMB166 million as compared to 31 December 2023. During the year, the Group maintained a healthy level of operating capital, and the net cash generated from operating activities increased compared to the previous year. The Company will continue to prudently assess its capital plan in light of market conditions and capital requirements to ensure maximum efficiency in the use of capital and to support its long-term development objectives.

Operational Summary

During the Year, the Group maintained its focus on the core strategy of “Single Brand, Multi-categories, Diversified Channels” to enhance product strength through continuous research and development and technological innovation. Furthermore, the Group made significant progress across various aspects of its business including product innovation, brand building, and channel optimization.

In 2024, the Group made multi-dimensional breakthroughs in the research and development of technologies. During the Year, the Group launched the new midsole technology “Super BOOM”(超䨻), which is not only lighter and more elastic but also boasts an exceptional elasticity-to-weight ratio, representing the pinnacle of performance for supercritical foaming materials. The BOOM technology platform has achieved four application breakthroughs within six years, evolving from a “single technology” to “four major technologies”. This progression demonstrates the Group’s commitment to exploring materials and manufacturing processes and exceptional ability to deploy and broaden their application, further enhancing its ability to diversify product offerings and iterate product lines.

In respect of branding and marketing, the Group continued to focus on the six core categories of running, basketball, training, badminton, table tennis, and sports casual. It also actively explored emerging sports and subcategories, such as outdoor sports, golf, tennis and pickleball. The Group leveraged technological innovation capabilities to drive product upgrades underpinned by three key pillars: solidifying a professional sports mindset, showcasing sports fashion aesthetics, and inheriting Chinese cultural values. Moreover, it proactively sought to strengthen its differentiated brand advantages and enhance brand influence through diversified and comprehensive marketing campaigns. Capitalizing on the market opportunities presented by a year distinguished major sporting events, the Group delved into the essence of its brand spirit and gained insights into the younger generation’s attitudes towards sports. Through these efforts, it articulated the brand spirit of “Dare to Imagine, Create Excellence, Anything is Possible”(敢於想像,創造精彩,一切皆有可能) and launched the “In My Name”(以我為名)-themed marketing campaign, aiming to solidify LI-NING’s professional image and establish a deeper emotional connection with consumers.

In respect of channel, the Group consolidated and enhanced operational efficiency for high-end markets and accelerate expansion into emerging markets. In the high-end markets, the Group focused on improving the efficiency of single store sales through a series of refined management processes and the orderly closure of stores with substantial losses to make the channel layout more reasonable, effectively enhancing overall channel efficiency. At the same time, the Group actively expanded its presence in emerging markets. Diversified sales strategies and flexible market response capabilities enable the Group to gradually expand its market share in emerging markets. As of 31 December 2024, the number of conventional stores, flagship stores, China LI-NING stores, factory outlets and multi-brand stores under the LI-NING brand (including LI-NING Core Brand and LI-NING YOUNG) amounted to 7,585, representing a net decrease of 83 POS as compared to 31 December 2023. The number of distributors was 41 (including sales channels of China LI-NING stores), representing a net decrease of 5 as compared to 31 December 2023.

In terms of retail operations, the Group intensified efforts to promote a single-store operational model with solid profit and efficiency. It established standard profit and loss models for stores at all levels, standardizing and quantifying core store metrics to link them with management objectives across departments. This formed an efficient and coordinated management system, contributing to improved overall operational efficiency. The Group also strengthened the synergies between inventory and sales planning for single-stores and was committed to achieving improvements in both operational efficiency and supply chain management, ensuring efficient and accurate resource allocation and profitability.

In terms of new retail business, the Group continued to deepen the construction of its new retail business system, focusing on enhancing digitalization and all-channel operational capabilities. The aim is to efficiently convert private traffic and steadily improve sales performance. The Group actively explored diversified business models such as acquiring traffic through popular social media platforms like Douyin (抖音) and collaborating online with core channels to broaden sales, increase the proportion of out-of-store sales, and empower stores with new retail capabilities.

In terms of e-commerce operations, facing intensified market competition and a sluggish consumption environment, the Group continued to deepen e-commerce reform and strengthened its core competitiveness in the e-commerce sector across the board through online and offline interaction, diversified marketing campaigns, and precise capture of major sales promotions.

In terms of supply chain, the Group focused on exploring and matching high-quality supply chain resources, gradually improving the supplier matrix for high-end and outdoor products to ensure precise alignment between products and supply chain resources. The Group also implemented a flexible supply chain strategy to closely monitor market demand. Initiatives to refine management and analyse digital information support interoperability and transparency, improve the level of automation, and significantly enhance inventory efficiency along the supply chain. While flexibly responding to market changes, the Group strived to achieve dual improvements in production efficiency and economic benefits.

In 2024, the Group made remarkable achievements in logistics. Four major regional logistics centres across the country underwent comprehensive automation upgrades and began operations. The Nanning central warehouse is set to begin operations in 2025, which will improve delivery efficiency and logistics and warehousing operational capabilities in the southwest of the country. The Group is also proactively promoting refined logistics plan management across its divisions. Through the optimization of digital tools, the Group catered to the specific needs of its sales teams, improved the efficiency of goods distribution, and reduced logistics costs.

In terms of kidswear business, LI-NING YOUNG refined its youth product offerings, leveraging the core competitiveness of its clothing and accessories, while actively expanded into emerging markets, improved single-store efficiency, strengthened construction of clearance channels, promoted product distribution, and expanded the customer base. In terms of retail operations, LI-NING YOUNG continued to enhance operational efficiency and actively acquire and convert customers. Meanwhile, the Group actively built a community marketing system to strengthen member interaction and provide exclusive benefits to strengthen member loyalty and sales conversion rates. In terms of marketing, LI-NING YOUNG planned a series of offline youth activities and cross-border collaborations, focusing on popular sports including basketball, football, running and outdoor activities to showcase the brand’s diverse appeal. Meanwhile, LI-NING YOUNG leveraged social media platforms, ensuring that its messaging reaches target audiences, drives engagement, and reinforces the concept of being a “professional youth sports brand”. As at 31 December 2024, the total number of LI-NING YOUNG POS amounted to 1,468, representing a net increase of 40 POS since 31 December 2023.

Outlook

Looking ahead, the Group will continue to fulfil its commitments by focusing on its core strategy of “Single Brand, Multi-categories, Diversified Channels”, and ensure its effective implementation by strengthening operational systems and consolidating foundational support.

1. Strengthen the implementation of core strategies. By maintaining the healthy development of its core businesses, the Group will further integrate resources and leverage the LI-NING technology platform to further improve its professional product offerings in subcategories such as running, basketball, training, badminton, table tennis and sports casual. It will also deepen the fusion of the sporting spirit and its brand to enhance its competitiveness and influence in core business areas. Meanwhile, in addition to active efforts to optimize its product structure, the Group will expand diversified dressing scenarios with a commitment to the single-brand strategy, deeply integrate sports fashion culture, and launch sports products that combine technology and fashion. In addition, it will take the lead in laying out new pathways for sports consumption, especially in the markets for women, outdoor and youth, striving to achieve breakthrough progress in these emerging fields and drive diversified business expansion. Moreover, the Group is committed to expanding its presence in all target markets, with the aim to create business opportunities in each channel, continuously enhance brand influence, and drive sustained business growth.

2. Optimize operational efficiency. The Group will focus on boosting operational efficiency to ensure the effective implementation of its “Single Brand, Multi-categories, Diversified Channels” strategy. Deepened cross-departmental collaboration and streamlined business processes will empower the Group with efficient product management operations and allchannel integration and supply chain collaboration. Meanwhile, the Group will adopt refined management practices and strictly control costs and benefits, to ensure optimal allocation of resources. At the organizational level, the Group will endeavour to streamline management levels, optimize talent structure, cultivate efficient teams, and promote collaboration among organizations, in order to accelerate the decision-making process, enhance execution, and build a flexible and efficient operational structure.

3. Reinforce underlying support. In terms of underlying support, the Group will ensure sound operations of its financial systems, strengthen fund management and optimize capital structure, and improve financial transparency in a way that provides a solid financial foundation for long-term development. At the same time, the Group will deepen the integration of digital and smart tools by applying digital and intelligent technologies to make more scientific business decisions and adapt with agility to market changes. Through data analysis, artificial intelligence and automation tools, the Group will enhance its insight into market trends and understanding of consumer behaviour, thereby driving innovation in products and services and providing strong support for sustained development.

Mr. Li Ning, Executive Chairman and Joint CEO of the Group, concluded, “Looking ahead to 2025, with strong policy support, consumer spending has the potential to grow decently in China. As a company with long-term roots in China market and a focus on professional products for sports, we are confident in our future development and will seize this opportunity to drive high-quality growth.

Notably, LI-NING will once again partner with the Chinese Olympic Committee and the Chinese Sports Delegation from 2025 to 2028, which underscores the full trust and responsibility bestowed by the General Administration of Sport of China and the Chinese Olympic Committee and the high recognition of the Group’s professionalism and innovation. By adhering to its core value of ‘serving the public with sportsmanship’, LI-NING is committed to becoming the most prominent and stylish sports brand from China and the preferred sports brand of Chinese consumers.”
Hashtag: #LiNing #Sportswear

The issuer is solely responsible for the content of this announcement.

About Li Ning Company Limited

Li Ning Company Limited is one of the leading sports brand companies in China, mainly operating professional and leisure footwear, apparel, equipment and accessories under the LI-NING brand. The Group has comprehensive research and development, design, manufacturing, marketing, distribution and retail management capabilities. It has established an extensive retail distribution network and supply chain management system in China. We are committed to be the most prominent, stylish, world-leading sports brand from China.

In addition to its core LI-NING brand, the Group also manufactures, develops, markets, distributes, sells various sports products which are self-owned by or licensed to the Group, including Double Happiness (table tennis), AIGLE (outdoor sports) and Kason (badminton), which are operated through joint venture/associate with third parties of the Group.

Continue Reading

Trending